Diabetes Patients at Risk From Rising Insulin Prices
A Yale study found that one in four patients admitted to cutting back on insulin use because of cost. The consequences can be deadly. (Source: NYT Health)
Source: NYT Health - June 22, 2018 Category: Consumer Health News Authors: RANDI HUTTER EPSTEIN, M.D. and RACHEL STRODEL Tags: Diabetes Insulin Health Insurance and Managed Care Drugs (Pharmaceuticals) Prices (Fares, Fees and Rates) Generic Brands and Products Source Type: news

FDA expands approval of Medtronic MiniMed 670G to include kids 7 and up
Children with Type 1 diabetes will now have access to the Medtronic MiniMed 670G, a hybrid closed-loop system insulin delivery system, following the FDA ’s decision to expand the product approval for a younger demographic.  (Source: mobihealthnews)
Source: mobihealthnews - June 22, 2018 Category: Information Technology Source Type: news

Tandem wins FDA nod for insulin pump with predictive low glucose suspend feature
The FDA this week approved Tandem Diabetes Care‘s (NSDQ:TNDM) t:slim X2 insulin pump with a predictive low glucose suspend feature designed to cut the frequency and duration of hypoglycemia. The San Diego, Calif.-based company said that upon launch, its new product will also feature Dexcom‘s (NSDQ:DXCM) G6 continuous glucose monitoring system. Tandem expects that the latest iteration of its insulin pump will be available in August. Get the full story at our sister site, Drug Delivery Business News. The post Tandem wins FDA nod for insulin pump with predictive low glucose suspend feature appeared ...
Source: Mass Device - June 22, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Pharmaceuticals Regulatory/Compliance Wall Street Beat Dexcom tandemdiabetes Source Type: news

Medtronic ’ s MiniMed system wins FDA nod for pediatric indication
The FDA this week expanded its approval for Medtronic‘s (NYSE:MDT) MiniMed 670G hybrid closed-loop diabetes management device to include people ages 7 to 13 with Type I diabetes. The system, which automatically monitors blood sugar levels and doses basal insulin accordingly, was initially approved in the U.S. for people ages 14 and older. Get the full story at our sister site, Drug Delivery Business News. The post Medtronic’s MiniMed system wins FDA nod for pediatric indication appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - June 22, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Food & Drug Administration (FDA) Pediatrics Pharmaceuticals Regulatory/Compliance Wall Street Beat Medtronic Source Type: news

FDA expands approval of hybrid closed loop system for monitoring and delivering insulin to pediatric patients as young as 7. #cgm #diabetes #pediatrics #fdaapproval #medicaldevice http://go.usa.gov/xUqgQ   pic.twitter.com/wZdrU6tTzf
FDA expands approval of hybrid closed loop system for monitoring and delivering insulin to pediatric patients as young as 7. #cgm #diabetes #pediatrics #fdaapproval #medicaldevice http://go.usa.gov/xUqgQ  pic.twitter.com/wZdrU6tTzf (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - June 22, 2018 Category: Medical Devices Authors: ( at FDADeviceInfo) Source Type: news

FDA approves automated insulin delivery and monitoring system for use in younger pediatric patients
(Source: Food and Drug Administration)
Source: Food and Drug Administration - June 21, 2018 Category: American Health Source Type: news

Companion Medical launches data management system for smart insulin pen
Companion Medical launched today Insights by InPen, a diabetes management system that aggregates and analyzes data from Companion’s connected insulin injection pen. The company’s Insights by InPen system provides users with their average glucose, average total daily insulin dose, dose calculator usage, missed doses and more, according to Companion Medical. Get the full story at our sister site, Drug Delivery Business News. The post Companion Medical launches data management system for smart insulin pen appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - June 21, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Companion Medical Source Type: news

There ’s Hope for a Vaccine to Prevent Type 1 Diabetes
Could a vaccine for type-1 diabetes be on the horizon? In a new study, a small group of people with type 1 diabetes who were given a vaccine showed improvement in their blood sugar levels to nearly normal levels—and the changes lasted for five to eight years. The study, published Thursday in the journal npj Vaccines by researchers at Massachusetts General Hospital, looked at nine people with type 1 diabetes who were given a vaccine to prevent tuberculosis, called bacillus Calmette-Guérin (BCG). They had two injections, four weeks apart. Levels of their hemoglobin a1c (HbA1c), which measures a person’s bl...
Source: TIME: Health - June 21, 2018 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized diabetes healthytime Source Type: news

Caffeine-activated implant may replace insulin injections
Swiss researchers have developed an implant that releases insulin in response to caffeine in the bloodstream, which could lead to new treatment strategies for diabetes, according to a study published inNature Communications.Guardian (Source: Society for Endocrinology)
Source: Society for Endocrinology - June 21, 2018 Category: Endocrinology Source Type: news

Caffeine-Triggered Cells Help Control Blood Sugar in Diabetic Mice
Scientists engineered human cells to produce a molecule that stimulates insulin secretion in the presence of caffeine. (Source: The Scientist)
Source: The Scientist - June 20, 2018 Category: Science Tags: News & Opinion Source Type: news

Lack of insulin tracking at care home left system open to abuse, Wettlaufer inquiry hears
Elizabeth Wettlaufer quit her job at Meadow Park Long-Term Care in London, Ont., the day after a large amount of narcotics went missing. She spent the weekend in hospital after overdosing, a public inquiry heard. (Source: CBC | Health)
Source: CBC | Health - June 20, 2018 Category: Consumer Health News Tags: News/Canada/London Source Type: news

Lack of insulin tracking at home where Wettlaufer worked allowed for abuse, inquiry hears
Insulin was easily accessible to nursing staff at Meadow Park Long-Term Care in London, Ont., where killer nurse Elizabeth Wettlaufer found her last victim, the home's former co-director of care testified Wednesday. (Source: CBC | Health)
Source: CBC | Health - June 20, 2018 Category: Consumer Health News Tags: News/Canada/London Source Type: news

Caffeine-sensitive cells may let diabetics control their blood sugar
Swiss scientists have developed specialized kidney cells that release insulin when caffeine is detected. Someday, these could allow diabetics to control their blood sugar with cups of coffee. (Source: the Mail online | Health)
Source: the Mail online | Health - June 20, 2018 Category: Consumer Health News Source Type: news

Could coffee replace insulin injections for diabetics?
Scientists have developed an implant which releases diabetes medication when it senses caffeine in the bloodThe days of the insulin pen may be numbered. According to researchers in Switzerland, the future of diabetes treatment will not be a shot in the arm after a meal, but a shot of espresso instead.The scientists hope to transform the lives of diabetics who need regular jabs with an implant that contains hundreds of thousands of designer cells which churn out medicine when they sense caffeine in the bloodstream.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 19, 2018 Category: Science Authors: Ian Sample Science editor Tags: Medical research Diabetes Genetics Science Coffee Source Type: news

Off-Label Antipsychotics Cause Adverse Metabolic Effects in Kids Off-Label Antipsychotics Cause Adverse Metabolic Effects in Kids
Off-label antipsychotic use in children and adolescents with behavioral disorders triggers rapid and significant metabolic effects including weight gain and decreased insulin sensitivity, new research shows.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 19, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Wettlaufer dressed up as Grim Reaper for Halloween at nursing home, inquiry told
When she dressed up as the Grim Reaper for the nursing home Halloween party, nurse Elizabeth Wettlaufer raised eyebrows, but her colleagues say they didn't know she was killing residents by injecting them with insulin. Wettlaufer's strange sense of humour and her inappropriateness with staff were discussed Monday at the Ontario public inquiry into long-term care that continues today. (Source: CBC | Health)
Source: CBC | Health - June 19, 2018 Category: Consumer Health News Tags: News/Canada/London Source Type: news

Vegetarian diets help type 2 diabetics lose weight and could prevent them dying of heart disease
Researchers from the Physicians Committee for Responsible Medicine, Washington DC, found that ditching meat improves type 2 diabetics' insulin and cholesterol levels, preventing heart attacks. (Source: the Mail online | Health)
Source: the Mail online | Health - June 19, 2018 Category: Consumer Health News Source Type: news

How AI Is Personalizing Insulin Therapy for Diabetes Patients
Artificial intelligence is increasingly playing a role in healthcare, especially in the diabetes management space. The latest example of this comes from Petah Tikva, Israel-based DreMed Diabetes and Mountain View, CA-based Glooko.  FDA has granted a de novo request for the DreaMed Advisor Pro, an AI-based diabetes treatment decision support software intended to help healthcare providers manage people with Type I diabetes who use insulin pumps and continuous glucose monitoring (CGM). DreaMed Advisor Pro is a cloud-based digital solution generating insulin designed to generate insulin delivery recommendations by analyzi...
Source: MDDI - June 18, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Digital Health Source Type: news

Federal Intervention Needed on Insulin Prices Federal Intervention Needed on Insulin Prices
Insulin prices have nearly tripled in a decade, putting the life-sustaining drug out of reach for some people with diabetes, and the American Medical Association is calling for more transparency.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 18, 2018 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Faulty Insulin Secretion Key to Glucose Dysregulation in PD? Faulty Insulin Secretion Key to Glucose Dysregulation in PD?
Patients with moderate to advanced Parkinson's disease exhibit higher glucose levels than healthy controls during glucose tolerance testing, without the expected rise of insulin.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - June 18, 2018 Category: Pathology Tags: Neurology & Neurosurgery News Source Type: news

DreaMed Diabetes wins FDA authorization to market insulin therapy management platform
DreaMed Diabetes said today that U.S. FDA has granted a de novo request for DreaMed Advisor Pro, its AI-based diabetes treatment decision support software. The news comes about four months after the Petah Tikva, Israel–based company won CE Mark clearance for the decision-support platform, which is meant to help healthcare professionals manage insulin therapy for people with Type I diabetes. Get the full story on our sister site Drug Delivery Business News. The post DreaMed Diabetes wins FDA authorization to market insulin therapy management platform appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - June 18, 2018 Category: Medical Devices Authors: Chris Newmarker Tags: Business/Financial News Diabetes Food & Drug Administration (FDA) Software / IT DreaMed Diabetes Source Type: news

Study: Almost half of diabetics skip medical care due to costs
Soaring insulin prices are prompting the American Medical Association to call for federal intervention (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 18, 2018 Category: Consumer Health News Source Type: news

Diabetes: Are you at risk? Check if you suffer from these five hazards
DIABETES type 2 happens when the body struggles to regulate blood sugar levels, due to problems with the hormone insulin. You are more likely to develop the condition in later life due to these risk factors. (Source: Daily Express - Health)
Source: Daily Express - Health - June 18, 2018 Category: Consumer Health News Source Type: news

Diabetes: Being overweight rasies your risk of developing this condition
DIABETES type 2 happens when the body struggles to regulate blood sugar levels, due to problems with the hormone insulin. You are more likely to develop the condition in later life due to these risk factors. (Source: Daily Express - Health)
Source: Daily Express - Health - June 18, 2018 Category: Consumer Health News Source Type: news

Diabetes: How to tell if you’re at risk of developing the condition
DIABETES type 2 happens when the body struggles to regulate blood sugar levels, due to problems with the hormone insulin. You are more likely to develop the condition in later life due to these risk factors. (Source: Daily Express - Health)
Source: Daily Express - Health - June 18, 2018 Category: Consumer Health News Source Type: news

Federal Government Must Tackle Rising Insulin Prices: AMA
Title: Federal Government Must Tackle Rising Insulin Prices: AMACategory: Health NewsCreated: 6/14/2018 12:00:00 AMLast Editorial Review: 6/15/2018 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - June 15, 2018 Category: Endocrinology Source Type: news

AMA: Federal Government Must Tackle Rising Insulin Prices
THURSDAY, June 14, 2018 -- U.S. officials need to take action to control spiking insulin prices, the American Medical Association (AMA) says. The Federal Trade Commission and the Justice Department should monitor insulin pricing and market... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 14, 2018 Category: Pharmaceuticals Source Type: news

Antipsychotic Tx Linked to Adiposity Changes in Youths
THURSDAY, June 14, 2018 -- Youth receiving antipsychotic treatment have adverse changes in adiposity and insulin sensitivity, with the greatest fat increases seen with olanzapine, according to a study published online June 13 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 14, 2018 Category: Pharmaceuticals Source Type: news

Kids on Antipsychotics May See Adverse Metabolic Effects (CME/CE)
(MedPage Today) -- Changes in adiposity, insulin sensitivity observed during 12 weeks of treatment (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - June 13, 2018 Category: Pediatrics Source Type: news

ADHD drugs may fuel obesity in children
Taking antipsychotic drugs for aggression and ADHD led to rapid weight gain and insulin sensitivity in children, a new Washington University and Florida Atlantic University study found. (Source: the Mail online | Health)
Source: the Mail online | Health - June 13, 2018 Category: Consumer Health News Source Type: news

No double-check on insulin at nursing home, Wettlaufer public inquiry hears
Nurses had easy access to insulin, and there were few checks to make sure patients were given the right dosage, a former colleague of killer nurse Elizabeth Wettlaufer says. (Source: CBC | Health)
Source: CBC | Health - June 13, 2018 Category: Consumer Health News Tags: News/Canada/London Source Type: news

Do Antipsychotic Meds for Kids Raise Diabetes Risk?
WEDNESDAY, June 13, 2018 -- Widely used antipsychotic medications for troubled kids and teens can trigger weight gain and decrease insulin sensitivity, putting them at increased risk for diabetes, according to a new study. Antipsychotic medications... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 13, 2018 Category: General Medicine Source Type: news

Diabetes type 2: Eat this to help maintain blood sugar levels
DIABETES type 2 is often triggered in later life due to problems with the hormone insulin, meaning the body can ’t control blood sugar levels. Treatment involves changes to diet and lifestyle, such as avoiding high sugar snacks. Eating this could help maintain your blood sugar levels. (Source: Daily Express - Health)
Source: Daily Express - Health - June 13, 2018 Category: Consumer Health News Source Type: news

Phys Ed: Exercise vs. Standing? You Probably Need to Do Both
Moderate exercise does different things to the body than incidental activities like standing up. (Source: NYT Health)
Source: NYT Health - June 13, 2018 Category: Consumer Health News Authors: GRETCHEN REYNOLDS Tags: Diabetes Chairs Exercise Cholesterol Weight Insulin Obesity Bicycles and Bicycling Heart Medicine and Health Source Type: news

Insulin...Getting Better All the Time
Title: Insulin...Getting Better All the TimeCategory: Doctor's& Expert's views on SymptomsCreated: 6/26/2001 5:05:00 AMLast Editorial Review: 6/13/2018 2:55:07 PM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - June 13, 2018 Category: Endocrinology Source Type: news

Insulin Resistance - Keypoints
Title: Insulin Resistance - KeypointsCategory: Doctor's& Expert's views on SymptomsCreated: 10/2/2001 9:36:00 PMLast Editorial Review: 6/13/2018 2:55:07 PM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - June 13, 2018 Category: Endocrinology Source Type: news

Diabetes type 2: Swap pastry for this 25p alternative to help control blood sugar levels
DIABETES type 2 is often triggered in later life due to problems with the hormone insulin, meaning the body can ’t control blood sugar levels. Treatment involves changes to diet and lifestyle to help maintain blood sugar levels. Replacing your pastry with this 25p snack could help you achieve this. (Source: Daily Express - Health)
Source: Daily Express - Health - June 13, 2018 Category: Consumer Health News Source Type: news

Youths prescribed antipsychotics gain body fat, have increased diabetes risk
(Washington University School of Medicine) Doctors sometimes prescribe antipsychotic drugs to treat behavior disorders in youths who don't respond to traditional medications. Researchers at Washington University School of Medicine in St. Louis and Florida Atlantic University have found that young people taking antipsychotics for as little as 12 weeks experience significant gains in body fat and also become less sensitive to insulin. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 13, 2018 Category: International Medicine & Public Health Source Type: news

Metabolic effects of antipsychotic medications in youths
(JAMA Network) Increases in body fat and decreases in insulin sensitivity were observed in youths with disruptive behavior disorders who were treated for the first time with antipsychotic medications during a 12-week randomized clinical trial. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 13, 2018 Category: International Medicine & Public Health Source Type: news

Johnson & Johnson OKs $2B LifeScan sale to Platinum Equity
Johnson & Johnson (NYSE:JNJ) said today that it accepted a binding offer of more than $2 billion from private equity shop Platinum Equity for its LifeScan blood glucose monitoring business as it moves toward the exit in the diabetes market. The New Brunswick, N.J.-based healthcare conglomerate early last year announced a strategic review of its LifeScan, Animas and Calibra Medical diabetes businesses and later elected to outright shutter the Animas insulin pump subsidiary. Get the full story at our sister site, Drug Delivery Business News. The post Johnson & Johnson OKs $2B LifeScan sale to Platinum ...
Source: Mass Device - June 13, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Diabetes Mergers & Acquisitions Wall Street Beat johnsonandjohnson LifeScan Inc. Source Type: news

J & amp;J Agrees to $2.1B Sale of LifeScan
It's official, Johnson & Johnson is pulling out of the blood glucose monitoring space.  The New Brunswick, NJ-based company reported Tuesday afternoon that it has accepted Platinum Equity's $2.1 billion offer for J&J's LifeScan business. As MD+DI previously reported, J&J has been entertaining the offer since March and was expected to respond by June 15. LifeScan is known to diabetes patients worldwide for its OneTouch brand of glucose meters, insulin pumps, and related products. J&J said the deal is expected to close by the end of the year, assuming it clears regulatory requirements and other...
Source: MDDI - June 12, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

The medicine keeping her alive was also killing her
Emmy Reeves had type 1 diabetes, but she was allergic to the insulin she needed to stay alive. She recently became the first child in nearly 20 years to undergo a pancreas transplant. What happened next was incredible. (Source: CNN.com - Health)
Source: CNN.com - Health - June 12, 2018 Category: Consumer Health News Source Type: news

Diabetes Putting Millions Of Americans At Risk, Prescription Hope,...
Prescription Hope works directly with U.S. pharmaceutical companies to provide affordable insulin and over 1,500 other medications.(PRWeb June 12, 2018)Read the full story at https://www.prweb.com/releases/2018/06/prweb15540037.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 12, 2018 Category: Pharmaceuticals Source Type: news

Is There an End in Sight for J & amp;J Divestitures?
Johnson & Johnson has received an offer for its sterilization unit. The New Brunswick, NJ-based company said Fortive is seeking to acquire the business for $2.7 billion. The sterilization business is part of the Ethicon division and earned about $775 million in sales in 2017. J&J has 120 days to accept the offer and if the deal goes through it could close no later than early 2019. Fortive said it would finance the acquisition through debt or equity and with available cash. The company said it expects the deal to add to adjusted earnings in the first full year after the transaction. "As we balance the interests...
Source: MDDI - June 11, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Sterilization Source Type: news

Diabetes type 2: 75p pasta alternative could help you control blood sugar
DIABETES type 2 happens when problems with insulin mean the body cannot regulate blood sugar levels normally. As part of the treatment, sufferers need change their diet to avoid having high blood sugar levels, which can lead to health complications. You could switch pasta for these foods to ensure you get good carbohydrates. (Source: Daily Express - Health)
Source: Daily Express - Health - June 10, 2018 Category: Consumer Health News Source Type: news

Diabetes type 2: Replace pasta with these foods to help control blood sugar levels
DIABETES type 2 happens when problems with insulin mean the body cannot regulate blood sugar levels normally. As part of the treatment, sufferers need change their diet to avoid having high blood sugar levels, which can lead to health complications. You could switch pasta for these foods to ensure you get good carbohydrates. (Source: Daily Express - Health)
Source: Daily Express - Health - June 10, 2018 Category: Consumer Health News Source Type: news

Diabetes type 2: Avoid these alcoholic drinks to maintain healthy blood sugar levels
DIABETES type 2 occurs later in life due to problems with the hormone insulin, meaning your body struggles to control blood sugar levels. Sufferers need to change their diet and monitor blood sugar levels regularly to avoid a spike, which if it lasts for a while could cause heart problems or kidney damage. (Source: Daily Express - Health)
Source: Daily Express - Health - June 9, 2018 Category: Consumer Health News Source Type: news

New hope for Type 1 diabetes
BRITISH scientists have made a major breakthrough in their understanding of Type 1 diabetes. They say the rapid decline in insulin production that causes the debilitating condition continues to fall over seven years and then stabilises. (Source: Daily Express - Health)
Source: Daily Express - Health - June 8, 2018 Category: Consumer Health News Source Type: news

Infant Omega-3 Supplementation Tied to Decreased Waist Size
FRIDAY, June 8, 2018 -- Omega-3 long-chain polyunsaturated fatty acids (n-3 LCPUFA) supplementation in infancy is associated with reduced insulin concentrations and insulin resistance in boys and reduced waist circumference in both sexes at age 5... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 8, 2018 Category: Pharmaceuticals Source Type: news

Beta Bionics and Senseonics Collaborate on AI-Driven Pancreas
Just a few weeks after Beta Bionics made headlines with an IDE approval for its artificial intelligence (AI) driven iLet bionic pancreas system, the company is in the spotlight again. This time, Beta Bionics is teaming up with Senseonics Holdings, a company that is developing an implantable continuous glucose monitoring (CGM) system. Under this agreement, Beta Bionics will integrate Germantown, MD-based Senseonics’ Eversense CGM system with the iLet. Real-time data generated by Eversense could serve as one CGM option to drive the fully autonomous iLet Bionic Pancreas system. The iLet consists of a dual-chamber, auton...
Source: MDDI - June 8, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Digital Health Source Type: news